Health Catalyst Stock News

Health Catalyst (NASDAQ:HCAT) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 2 0 0 0 Last

HCAT earnings call for the period ending December 31, 2021.

HCAT earnings call for the period ending December 31, 2021.

Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q4 2021 Results - Earnings Call Transcript

Health Catalyst (HCAT) delivered earnings and revenue surprises of 9.52% and 2.60%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Health Catalyst press release (HCAT): Q4 Non-GAAP EPS of -$0.19 beats by $0.02.Revenue of $64.72M (+21.7% Y/Y) beats by $1.55M.

SOUTH JORDAN, Utah, March 01, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2021.

Health Catalyst (HCAT) delivered earnings and revenue surprises of 9.52% and 2.60%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Health Catalyst (NASDAQ:HCAT) is scheduled to announce Q4 earnings results on Tuesday, March 1st, after market close.The consensus EPS Estimate is -$0.21 (-31.2% Y/Y) and the…

Axonics (AXNX) delivered earnings and revenue surprises of 5.56% and 6.70%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Cerner (CERN) delivered earnings and revenue surprises of 5.68% and 2.27%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Health Catalyst (HCAT) has agreed to acquire healthcare analytics company, KPI Ninja.Financial terms of the deal were not revealed.Based in Lincoln, Nebraska, KPI Ninja

Health Catalyst Inc (HCAT) shares closed today at 1.6% above its 52 week low of $26.74, giving the company a market cap of $1B. The stock is currently down 28.5% year-to-date, down 44.2% over the past 12 months, and down 27.7% over the past five years. This week, the Dow Jones Industrial Average fell 2.5%, and the S&P 500 fell 2.7%. Trading Activity Trading volume this week was 26.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 5.7% lower than its 5-day moving average, 6.6% lower than its 20-day moving average, and 31.9% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 92.9% The company's stock price performance over the past 12 months lags the peer average by 48.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

10x Genomics (TXG) delivered earnings and revenue surprises of -166.67% and 2.83%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?